Canada· CA-DIN-02549980
TIBSOVO
A medicinal product containing ivosidenib, registered in Canada by SERVIER CANADA INC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- IVOSIDENIB
- Manufacturer
- SERVIER CANADA INC
- Country
- Canada (CA)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ivosidenib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomTibsovo 250mg tabletsServier Laboratories Ltd
- BelgiumTibsovo 250 mgLes Laboratoires Servier
- SwitzerlandTibsovo 250 mg, comprimés pelliculésServier (Suisse) SA
- CzechiaTIBSOVOLes Laboratoires Servier, Suresnes cedex
- SpainTIBSOVO 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULALes Laboratoires Servier
- FinlandTibsovoLes Laboratoires Servier
- FranceTIBSOVO 250 mg, comprimé pelliculéLES LABORATOIRES SERVIER
- IrelandTibsovo 250 mg Film-coated tabletLes Laboratoires Servier
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tibsovo
- Liechtenstein · Tibsovo
- Norway · Tibsovo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b2189563-8d3f-4948-8e83-f29ea6ad11d4 GET /v1/drugs/b2189563-8d3f-4948-8e83-f29ea6ad11d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02549980",
"form": "TABLET (IMMEDIATE RELEASE)",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": null,
"schedule": [
"Prescription"
],
"drug_code": "103879",
"strengths": [
"250 MG"
],
"ahfs_class": null,
"substances": [
"IVOSIDENIB"
],
"product_categorization": null
}See everything about ivosidenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.